SCHEMBL7035394

SCHEMBL7035394

CC(=CC(C)O)C(=O)OCCO

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
ALDH1A1 P00352 1/20 0.33
ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28790908 0.86 TSHR (0.38) TSHRALDH1A1ACHE
SCHEMBL27975126 0.85 HCAR2 (0.37) TSHRALDH1A1
SCHEMBL28040661 0.81 ACHE (0.36) TSHRACHE
SCHEMBL28101258 0.81 ALDH1A1 (0.48) TSHRALDH1A1
SCHEMBL28049970 0.81 TSHR (0.34) TSHR
SCHEMBL27570223 0.80 GLO1 (0.45) TSHRALDH1A1
SCHEMBL3283172 0.79 CYP3A4 (0.31) TSHR
SCHEMBL28421749 0.79 TSHR (0.54) TSHRALDH1A1
SCHEMBL17222436 0.79 TSHR (0.54) TSHRALDH1A1
SCHEMBL10730885 0.78 TSHR (0.34) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101544712-A Method for preparing phase-transition capsule dispersion liquid through mini-emulsion polymerization UNIV ZHEJIANG 2009-09-30 CN claimed
CN-113354780-B Double-layer bowl-shaped polymer hollow mesoporous nano material and preparation method thereof 重庆邮电大学 2022-11-08 CN disclosed
CN-101544712-A Method for preparing phase-transition capsule dispersion liquid through mini-emulsion polymerization UNIV ZHEJIANG 2009-09-30 CN disclosed
US-6833394-B2 Prepared by hydrolytic co-condensation of tetraalkoxysilanes with chromophoric trialkoxysilanes and optionally further metal alkoxides. IVOCLAR VIVADENT AG (LI) 2004-12-21 US disclosed
US-20030060536-A1 Polymerizable dental material based on chromophoric xerogels IVOCLAR VIVADENT AG (LI) 2003-03-27 US disclosed
EP-0675362-B1 Minimizing interferences in chemiluminescent thin-film immunoassays JOHNSON & JOHNSON CLIN DIAG (US) 2000-09-27 EP disclosed
EP-0609061-B1 Polymerizable composition, polymer, organic glass and ophthalmic lens TOKUYAMA CORP (JP) 1999-09-29 EP disclosed
EP-0458485-B1 Image forming layer FUJI PHOTO FILM CO LTD (JP) 1998-07-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060536-A1 Polymerizable dental material based on chromophoric xerogels SCO2, HBG1, HBG2 TSHR 3106/4885ALDH1A1 3750/4885ACHE 3994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.